Log In
BCIQ
Print this Print this
 

sitagliptin/atorvastatin (MK-0431E)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionCombination of sitagliptin and atorvastatin
Molecular Target Dipeptidyl peptidase-1 (DPP-1) (CTSC) ; HMG-CoA reductase
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today